Frederick National Laboratory: Monoclonal Antibody is Effective in Targeting Pancreatic Cancer Cells
August 15, 2025
August 15, 2025
FREDERICK, Maryland, Aug. 15 (TNSjou) -- The National Institutes of Health's National Laboratory for Cancer Research issued the following news:
* * *
Monoclonal antibody is effective in targeting pancreatic cancer cells
By Frank Blanchard
Scientists developed a monoclonal antibody (mAb) that selectively targets pancreatic cancer cells. This is an early step toward new treatments for a deadly malignancy that is the third leading cause of ca . . .
* * *
Monoclonal antibody is effective in targeting pancreatic cancer cells
By Frank Blanchard
Scientists developed a monoclonal antibody (mAb) that selectively targets pancreatic cancer cells. This is an early step toward new treatments for a deadly malignancy that is the third leading cause of ca . . .